Page last updated: 2024-09-05

erlotinib hydrochloride and Spider Veins

erlotinib hydrochloride has been researched along with Spider Veins in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lacouture, ME; Mitchell, EP; Perez-Soler, R; Van Cutsem, E	1

Reviews

1 review(s) available for erlotinib hydrochloride and Spider Veins

Article	Year
Clinical presentation and pathophysiology of EGFRI dermatologic toxicities. Oncology (Williston Park, N.Y.), 2007, Volume: 21, Issue:11 Suppl 5 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Hair Diseases; Humans; Lapatinib; Nail Diseases; Panitumumab; Protein Kinase Inhibitors; Quinazolines; Telangiectasis	2007

Article

Year

Clinical presentation and pathophysiology of EGFRI dermatologic toxicities.

Oncology (Williston Park, N.Y.), 2007, Volume: 21, Issue:11 Suppl 5

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Hair Diseases; Humans; Lapatinib; Nail Diseases; Panitumumab; Protein Kinase Inhibitors; Quinazolines; Telangiectasis

2007